Medical devices, healthcare technology and the business of care
510(k) clearance · K262667

PeekMed web

Peek Health, S.A. · Decision date Nov 4, 2026

FDA DECISIONK262667

What did the FDA decide?

FDA records K262667 as a 510(k) premarket notification, with a decision dated Nov 4, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Nov 4, 2026

FDA source record

Regulatory record facts

Identifier
K262667
Regulatory pathway
510(k) premarket notification
Product code
QIH
Decision code
SESE
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Product code
QIH
FDA device class
2

FDA decision timeline

  1. K262667 received

    Application receipt date recorded by FDA.

  2. K262667 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA
Medis Medical Imaging Systems BV510(k) clearanceOct 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Peek Health, S.A.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Braga

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records